Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high‐grade premalignant gastric lesions

Helicobacter pylori (Hp) infects the stomach of about half of the human population and is strongly associated with the risk of gastric cancer (GC) and its premalignant precursors. The cag pathogenicity island (cagPAI) is a region of the Hp genome encoding for key molecular machinery involved in the infection process. Following a sequencing study, we selected 50 genetic polymorphisms located in seven cagPAI genes and tested their associations with the risk of advanced gastric premalignant lesions and GC in 1220 subjects from various Latin American populations showing the whole spectrum of phenotypes from gastritis to GC. We found that three polymorphisms of cagA are associated with the risk of advanced gastric premalignant lesions (incomplete intestinal metaplasia [ie, Type 2 and 3] or dysplasia), and that six polymorphisms located in cagA, cagL and cagI were associated with risk of GC. When corrected for multiple testing none of the associations were statistically significant. However, scores built by integrating the individual polymorphisms were significantly associated with the risk of advanced gastric premalignant lesions and GC. These results have the potential of establishing markers for risk stratification in the general population, in view of targeting Hp eradication to high‐risk population groups.

[1]  C. Rizzato,et al.  Variations in cag pathogenicity island genes of Helicobacter pylori from Latin American groups may influence neoplastic progression to gastric cancer , 2020, Scientific Reports.

[2]  M. Zali,et al.  Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases , 2019, Cancer medicine.

[3]  Carlos A Castañón-Sánchez,et al.  CagL polymorphisms D58/K59 are predominant in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis , 2019, Gut Pathogens.

[4]  D M Parkin,et al.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.

[5]  R. Alizadeh-Navaei,et al.  Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection , 2018, Alimentary pharmacology & therapeutics.

[6]  H. Nouri,et al.  Helicobacter pylori cagL amino acid polymorphism D58E59 pave the way toward peptic ulcer disease while N58E59 is associated with gastric cancer in north of Iran. , 2017, Microbial pathogenesis.

[7]  T. Azuma,et al.  Genetic variants of Helicobacter pylori type IV secretion system components CagL and CagI and their association with clinical outcomes , 2017, Gut Pathogens.

[8]  M. Hatakeyama,et al.  Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein , 2017, Toxins.

[9]  D. Falush,et al.  Correction: Rapid evolution of distinct Helicobacter pylori subpopulations in the Americas , 2017, PLoS genetics.

[10]  Yuan Yuan,et al.  Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks , 2017, Medicine.

[11]  C. Rizzato,et al.  Whole Genome Sequence and Phylogenetic Analysis Show Helicobacter pylori Strains from Latin America Have Followed a Unique Evolution Pathway , 2017, Front. Cell. Infect. Microbiol..

[12]  D. Falush,et al.  Rapid evolution of distinct Helicobacter pylori subpopulations in the Americas , 2016, bioRxiv.

[13]  T. Kwok,et al.  Helicobacter pylori CagL Hypervariable Motif: A Global Analysis of Geographical Diversity and Association With Gastric Cancer. , 2016, The Journal of infectious diseases.

[14]  T. Kwok,et al.  Preservation of Helicobacter pylori CagA Translocation and Host Cell Proinflammatory Responses in the Face of CagL Hypervariability at Amino Acid Residues 58/59 , 2015, PloS one.

[15]  C. Maldonado-Bernal,et al.  Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa , 2015, Innate immunity.

[16]  Jin Myung Choi,et al.  Crystal structure of CagL from Helicobacter pylori K74 strain. , 2015, Biochemical and biophysical research communications.

[17]  K. Diederichs,et al.  Integrin Engagement by the Helical RGD Motif of the Helicobacter pylori CagL Protein Is Regulated by pH-induced Displacement of a Neighboring Helix* , 2015, The Journal of Biological Chemistry.

[18]  S. Backert,et al.  Structure of a three-dimensional domain-swapped dimer of the Helicobacter pylori type IV secretion system pilus protein CagL. , 2014, Acta crystallographica. Section D, Biological crystallography.

[19]  B. Peleteiro,et al.  Prevalence of Helicobacter pylori Infection Worldwide: A Systematic Review of Studies with National Coverage , 2014, Digestive Diseases and Sciences.

[20]  M. Shariq,et al.  Cag Type IV Secretion System: CagI Independent Bacterial Surface Localization of CagA , 2013, PloS one.

[21]  J. Gaddy,et al.  Functional Plasticity in the Type IV Secretion System of Helicobacter pylori , 2013, PLoS pathogens.

[22]  D. Morgan,et al.  Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) , 2013, Cancer Causes & Control.

[23]  E. Kasamatsu,et al.  The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries , 2013, Cancer Causes & Control.

[24]  F. Inagaki,et al.  Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. , 2012, Cell host & microbe.

[25]  Jing Hu,et al.  SIFT web server: predicting effects of amino acid substitutions on proteins , 2012, Nucleic Acids Res..

[26]  G. Rieder,et al.  Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin–integrin linked kinase signalling complex , 2012, Gut.

[27]  M. Plummer,et al.  Variations in Helicobacter pylori Cytotoxin-Associated Genes and Their Influence in Progression to Gastric Cancer: Implications for Prevention , 2012, PloS one.

[28]  Yi-Chun Yeh,et al.  H. pylori cagL amino acid sequence polymorphism Y58E59 induces a corpus shift of gastric integrin α5β1 related with gastric carcinogenesis , 2011, Molecular carcinogenesis.

[29]  J. C. Robayo,et al.  Asociación de los polimorfismos IL-1B-511 e IL-1RN y Helicobacter pylori CagA positivo con cáncer gástrico en una zona de riesgo alto en Colombia , 2011 .

[30]  P. Christie,et al.  Evidence for VirB4-Mediated Dislocation of Membrane-Integrated VirB2 Pilin during Biogenesis of the Agrobacterium VirB/VirD4 Type IV Secretion System , 2010, Journal of bacteriology.

[31]  C. Maldonado-Bernal,et al.  TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. , 2008, Clinical immunology.

[32]  M. Piazuelo,et al.  Natural history of Helicobacter pylori infection. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[33]  M. Plummer,et al.  Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.

[34]  Stef van Buuren,et al.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007 .

[35]  J. Puente,et al.  Heterogeneity in the Activity of Mexican Helicobacter pylori Strains in Gastric Epithelial Cells and Its Association with Diversity in the cagA Gene , 2007, Infection and Immunity.

[36]  M. Hatakeyama.  Helicobacter pylori CagA—a bacterial intruder conspiring gastric carcinogenesis , 2006, International journal of cancer.

[37]  M. Achtman,et al.  Characterization of the Pilin Ortholog of the Helicobacter pylori Type IV cag Pathogenicity Apparatus, a Surface-Associated Protein Expressed during Infection , 2006, Journal of bacteriology.

[38]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[39]  S. Ahrné,et al.  Multiple displacement amplification of DNA from human colon and rectum biopsies: bacterial profiling and identification of Helicobacter pylori-DNA by means of 16S rDNA-based TTGE and pyrosequencing analysis. , 2005, Journal of microbiological methods.

[40]  M. Plummer,et al.  Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  Takeshi Azuma,et al.  SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein , 2001, Science.

[42]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[43]  A. Helicobacter,et al.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.

[44]  P. Sharp,et al.  Absence of translationally selected synonymous codon usage bias in Helicobacter pylori. , 2000, Microbiology.

[45]  M. Borodovsky,et al.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Peterson,et al.  Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems , 1993, Journal of clinical microbiology.

[47]  M. Bravo,et al.  [Association of interleukin-1 genetic polymorphism and CagA positive Helicobacter pylori with gastric cancer in Colombia]. , 2011, Revista medica de Chile.

[48]  S. Shao,et al.  Characterization of peptidoglycan hydrolase in Cag pathogenicity island of Helicobacter pylori , 2010, Molecular Biology Reports.

[49]  WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 2003 .

[50]  N. Muñoz,et al.  Prevalence of precancerous lesions of the stomach in Venezuela. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.